CONTINENTAL ADVISORS LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1277779 Park City, UT

Position in BMY

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$4,537,805

+$307,225 QoQ

Shares Held

78,754

+12.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

2.84%

of 13F equity value

Holder Rank

#573

of 2,506 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CONTINENTAL ADVISORS LLC holds $18,125,438 across 3 Drug Manufacturers - General names. BMY ranks #2 (25.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	415,438	$10,003,747
2	BMY	Bristol Myers Squibb Co This page	78,754	$4,537,805
3	GILD	Gilead Sciences, Inc.	28,367	$3,583,886

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,537,805	78,754	+12.9%	Shares	Sole	2026-07-27
2026-03-31	$4,230,580	69,754	-6.7%	Shares	Sole	2026-05-15
2025-12-31	$4,032,230	74,754	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.